HTR2A and fatty liver disease: Furthermore, compared to HFD-fed WT mice, HFD-fed MC4RKO mice showed more severe hepatic steatosis and TG content increase and milder recovery of these parameters after peripheral neural blockade and treatment with the HTR2A antagonist.